Skip to content

Clinical trials

Phase 3 Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 3 Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20024
20032
20043
20052
20063
20074
20086
20091
20112
20122
20142
20172
20193
20211
20231
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Unknown status8
Active, not recruiting5
Recruiting5
Terminated5
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group8
National Cancer Institute (NCI)6
German High-Grade Non-Hodgkin's Lymphoma Study Group4
Alliance for Clinical Trials in Oncology3
European Organisation for Research and Treatment of Cancer - EORTC3
Fred Hutchinson Cancer Center3
Memorial Sloan Kettering Cancer Center3
Cancer Research Campaign Clinical Trials Centre2
Gustave Roussy, Cancer Campus, Grand Paris2
Jonsson Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma67
Precursor Cell Lymphoblastic Leukemia-Lymphoma45
Lymphoma, Large B-Cell, Diffuse44
Lymphoma, Follicular40
Lymphoma, Non-Hodgkin39
Lymphoma, Large-Cell, Immunoblastic38
Lymphoma, Mantle-Cell38
Lymphoma37
Lymphoma, B-Cell, Marginal Zone35
Leukemia, Lymphocytic, Chronic, B-Cell34

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.